GL1X · GenesisL1 explorer

Research workbench

HIV1 catalytic core domain in complex with an inhibitor (2~{S})-2-[3- (3,4-dihydro-2~{H}-chromen-6-yl)-1-methyl-indol-2-yl]-2-[(2- methylpropan-2-YL)OXY]ETHANOIC acid

Analyse HIV1 catalytic core domain in complex with an inhibitor (2~{S})-2-[3… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5KGX
Type
protein
Length
136 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrase
UniProt
Q76353
Ligands
7SK, SO4

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIntegraseprotein13647% helix, 21% strandQ76353

Ligands and binding sites

  • 7SK · (2S)-tert-butoxy[3-(3,4-dihydro-2H-1-benzopyran-6-yl)-1-methyl-1H-indol-2-yl]acetic acid · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Modifications

Observed in the structure: 2 modified (nonstandard).

Compared structures

  • 5KGX · HIV1 catalytic core domain in complex with an inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.